Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Menczer

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Gynecologic Oncology|January 24, 2007
Efficacy and toxicity of weekly topotecan in recurrent epithelial ovarian and primary peritoneal cancerTamar Safra, Joseph Menczer, Rinat Bernstein, et al.
American Journal of Obstetrics and Gynecology|May 1, 2004
Comparison between primary peritoneal and epithelial ovarian carcinoma: a population-based studyGiulia Barda, Joseph Menczer, Angela Chetrit, et al.
Gynecologic Oncology|May 17, 2005
Demographic and genetic characteristics of patients with borderline ovarian tumors as compared to early stage invasive ovarian cancerWalter H Gotlieb, Angela Chetrit, Joseph Menczer, et al.
Gynecologic Oncology|May 19, 2009
Combined weekly carboplatin and paclitaxel as primary treatment of advanced epithelial ovarian carcinomaTamar Safra, Joseph Menczer, Rinat Molho Bernstein, et al.
Acta Oncologica (Stockholm, Sweden)|June 9, 2006
Heavily pretreated ovarian cancer patients treated by single-agent gemcitabine. A retrospective outcome comparison between platinum-sensitive and platinum-resistant patientsTamar Safra, Ilan Ron, Mona Boaz, et al.
Journal of the National Cancer Institute|July 17, 2003
Gynecologic surgeries and risk of ovarian cancer in women with BRCA1 and BRCA2 Ashkenazi founder mutations: an Israeli population-based case-control studyJoni L Rutter, Sholom Wacholder, Angela Chetrit, et al.
The Lancet. Oncology|July 24, 2009
TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studiesStefanie J Klug, Meike Ressing, Jochem Koenig, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Gynecologic Oncology|January 24, 2007
Efficacy and toxicity of weekly topotecan in recurrent epithelial ovarian and primary peritoneal cancerTamar Safra, Joseph Menczer, Rinat Bernstein, et al.
American Journal of Obstetrics and Gynecology|May 1, 2004
Comparison between primary peritoneal and epithelial ovarian carcinoma: a population-based studyGiulia Barda, Joseph Menczer, Angela Chetrit, et al.
Gynecologic Oncology|May 17, 2005
Demographic and genetic characteristics of patients with borderline ovarian tumors as compared to early stage invasive ovarian cancerWalter H Gotlieb, Angela Chetrit, Joseph Menczer, et al.
Gynecologic Oncology|May 19, 2009
Combined weekly carboplatin and paclitaxel as primary treatment of advanced epithelial ovarian carcinomaTamar Safra, Joseph Menczer, Rinat Molho Bernstein, et al.
Acta Oncologica (Stockholm, Sweden)|June 9, 2006
Heavily pretreated ovarian cancer patients treated by single-agent gemcitabine. A retrospective outcome comparison between platinum-sensitive and platinum-resistant patientsTamar Safra, Ilan Ron, Mona Boaz, et al.
Journal of the National Cancer Institute|July 17, 2003
Gynecologic surgeries and risk of ovarian cancer in women with BRCA1 and BRCA2 Ashkenazi founder mutations: an Israeli population-based case-control studyJoni L Rutter, Sholom Wacholder, Angela Chetrit, et al.
The Lancet. Oncology|July 24, 2009
TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studiesStefanie J Klug, Meike Ressing, Jochem Koenig, et al.
Pageof 5